financetom
Business
financetom
/
Business
/
Anaergia Signs Contract for Anaerobic Digestion Facility in Italy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Anaergia Signs Contract for Anaerobic Digestion Facility in Italy
Aug 6, 2025 4:14 AM

06:55 AM EDT, 08/06/2025 (MT Newswires) -- Anaergia ( ANRGF ) on Wednesday said a subsidiary signed a third contract to develop a biomethane production plant in Ostellato, Italy.

The contract was signed with QGM, an entity owned by a partnership between Quercus Real Assets and Elionia. The plant will leverage Anaergia's ( ANRGF ) anaerobic digestion technologies to produce renewable biomethane from agricultural residues.

The facility will process approximately 47,000 tons per year of agricultural biomass and by-products to produce over 4 million cubic meters of methane per year.

The plant is expected to be fully constructed and able to provide renewable biomethane to Italy's gas pipeline grid by mid-2026.

Anaergia's ( ANRGF ) total contracted value for the project exceeds $22 million.

"By adding this third facility to the others previously announced by QGM and Anaergia ( ANRGF ), we are fully on track to pursue our strategy to build a leading biomethane portfolio in Italy over the next years," said Elionia CEO and founder Danilo Fumarola.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trident Digital Tech Acquires 30% Stake in Tongxin for $3 Million
Trident Digital Tech Acquires 30% Stake in Tongxin for $3 Million
Aug 18, 2025
07:39 AM EDT, 08/18/2025 (MT Newswires) -- Trident Digital Tech ( TDTH ) said Monday that it has agreed to acquire a 30% equity stake in Tongxin Innovation for approximately $3 million. Tongxin Innovation operates the ToMe Web 3.0 e-commerce platform on Telegram. The company said the deal, which values Tongxin at approximately $10 million, will be completed by issuing...
Traws Pharma Gets Approval for Phase 2 COVID Studies With Ratutrelvir; Shares up Pre-Bell
Traws Pharma Gets Approval for Phase 2 COVID Studies With Ratutrelvir; Shares up Pre-Bell
Aug 18, 2025
07:39 AM EDT, 08/18/2025 (MT Newswires) -- Traws Pharma ( TRAW ) said Monday it received approval from the Human Research Ethics Committee to proceed with a phase 2 study of ratutrelvir to treat patients with newly diagnosed COVID. The first trial will allow the company to compare ratutrelvir with Pfizer's ( PFE ) Paxlovid. Traws Pharma ( TRAW )...
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease
Aug 18, 2025
07:39 AM EDT, 08/18/2025 (MT Newswires) -- Labcorp Holdings ( LH ) said Monday that Lumipulse, the first blood test cleared by the US Food and Drug Administration to help diagnose Alzheimer's disease, is now available nationwide. The test offers results that are comparable to existing methods, but is less invasive and more affordable and accessible, the company said. Lumipulse...
FibroGen Says China Unit Sale to AstraZeneca Receives Regulatory Approval
FibroGen Says China Unit Sale to AstraZeneca Receives Regulatory Approval
Aug 18, 2025
07:44 AM EDT, 08/18/2025 (MT Newswires) -- FibroGen ( FGEN ) said Monday the China State Administration for Market Regulation has approved the sale of its subsidiary in China to AstraZeneca ( AZN ) unit AstraZeneca Treasury. FibroGen ( FGEN ) said the transaction remains on track to close in Q3, pending other contractual conditions and deliverables. FibroGen ( FGEN...
Copyright 2023-2026 - www.financetom.com All Rights Reserved